Nephros Inc(NEPH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
October 7 at 4:00 PM ET (Korea 10/8 05:00)
Full metrics table
| Index | - | P/E | 20.45 | EPS (ttm) | 0.16 | Insider Own | 19.47% | Shs Outstand | 10.9M | Perf Week | -13.75% |
| Market Cap | 0.03B | Forward P/E | 12.31 | EPS next Y | 65.96% | Insider Trans | - | Shs Float | 8.8M | Perf Month | -26.61% |
| Enterprise Value | 0.03B | PEG | 0.29 | EPS next Q | 0.02 | Inst Own | 17.83% | Short Float | 0.53% | Perf Quarter | -8.57% |
| Income | 0.00B | P/S | 1.68 | EPS this Y | 42.42% | Inst Trans | -39.23% | Short Ratio | 1.87 | Perf Half Y | 9.97% |
| Sales | 0.02B | P/B | 2.9 | EPS next 5Y | 42.75% | ROA | 12.39% | Short Interest | 0.05M | Perf YTD | -34.43% |
| Book/sh | 1.1 | P/C | 7.39 | EPS past 3/5Y | - | ROE | 16.1% | 52W High | -50.16% ($6.42) | Perf Year | -43.66% |
| Cash/sh | 0.43 | P/FCF | 21.06 | Sales past 3/5Y | 23.5% 17.02% | ROIC | 13.97% | 52W Low | 20.17% ($2.66) | Perf 3Y | 111.92% |
| Dividend Est. | - | EV/EBITDA | 17.47 | EPS Y/Y TTM | 28.29% | Gross Margin | 60.66% | Volatility(W/M) | 10.37% 7.72% | Perf 5Y | -59.34% |
| Dividend TTM | - | EV/Sales | 1.49 | Sales Y/Y TTM | 24.2% | Oper. Margin | 7.92% | ATR (14) | 0.34 | Perf 10Y | 12.87% |
| Dividend Ex-Date | - | Quick Ratio | 2.71 | EPS Q/Q | 391.78% | Profit Margin | 8.38% | RSI (14) | 31.88 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.07 | Sales Q/Q | 36.16% | SMA20 | -20.49% ($4.02) | Beta | 1.73 | Target Price | $6.25 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2026/8/6 | SMA50 | -21.89% ($4.1) | Rel Volume | 1.87 | Prev Close | $3.02 |
| Employees | 36 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | 3233.33% 20.49% | SMA200 | -15.44% ($3.78) | Avg Volume(3M) | 0.02M | Price | $3.2 |
| IPO | 2004/9/21 | Option/Short | No/Yes | Trades | 583 | Volume | 46,506 | Change | 5.96% |
💧 Nephros() is a U.S.-based water treatment and medical filter specialist headquartered in New Jersey. The company supplies ultrafine filters built on hollow-fiber membrane technology to hospitals, dialysis centers, and commercial facilities. Its product range covers infection control, dialysis water purification, commercial drinking water, and PFAS (forever chemicals) removal, and it is a small profitable company that has posted four consecutive quarters in the black.
Over the past 1 year, on the lower side
50% below its 1-year high.
Traded more than usual That is 187% of its average volume.
NEPH makes money exceptionally well
Of every $100 in sales, $7.92 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +42.4% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,045. Peers typically go for $3,486. Compared with its own 2-year average, it is 38% cheaper now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -59.3%. The S&P 500 did +77% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 17.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #43 of 51 in the industry
Based on market cap of $35M.
FAQ
What kind of company is NEPH?
NEPH belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of NEPH?
The market cap of NEPH is approximately $35M, ranking 5,089 within its sector.
What is the P/E ratio of NEPH?
NEPH has a P/E ratio of approximately 20.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for NEPH?
NEPH has recorded a 52-week high of $6.42 and a low of $2.66.
